Analysing health outcomes variation for learning, improvement and better value care

19/01

Health systems across Europe are confronting significant challenges. Ageing populations, a rising burden of chronic disease, and a more challenging…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

The Policy Working Group (PWG) at EATG is pleased to share this new resource: Access to highly effective hepatitis C…

STEPS – HIV Cure Community Workshop in Glasgow – Final Report now out

15/12

On the 22nd of October, in Glasgow, the European AIDS Treatment Groups held the third edition of Steps – a…

Managing HIV in the aging population

23/01

Long-term care for an aging HIV population is uncharted territory, as researchers and physicians are seeing the effects of the…

Opportunities for addiction care and HIV prevention in Russia

23/01

Agonist therapy with methadone could use existing structure to reduce addiction, HIV Opioid agonist therapy using methadone is regarded as…

GeoVax announces initiation of HIV human clinical trial

23/01

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today (January 23) the initiation of the next…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

The Policy Working Group (PWG) at EATG is pleased to share this new resource: Access to highly effective hepatitis C…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…

Analysing health outcomes variation for learning, improvement and better value care

19/01

Health systems across Europe are confronting significant challenges. Ageing populations, a rising burden of chronic disease, and a more challenging…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

The Policy Working Group (PWG) at EATG is pleased to share this new resource: Access to highly effective hepatitis C…

STEPS – HIV Cure Community Workshop in Glasgow – Final Report now out

15/12

On the 22nd of October, in Glasgow, the European AIDS Treatment Groups held the third edition of Steps – a…

Managing HIV in the aging population

23/01

Long-term care for an aging HIV population is uncharted territory, as researchers and physicians are seeing the effects of the…

Opportunities for addiction care and HIV prevention in Russia

23/01

Agonist therapy with methadone could use existing structure to reduce addiction, HIV Opioid agonist therapy using methadone is regarded as…

GeoVax announces initiation of HIV human clinical trial

23/01

GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today (January 23) the initiation of the next…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

The Policy Working Group (PWG) at EATG is pleased to share this new resource: Access to highly effective hepatitis C…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…